Potential Health Benefits and Adverse Effects Associated with Phytate in Foods: A Review

Habtamu Fekadu Gemede

Authors

Habtamu Fekadu Gemede

Keywords:

antinutrient, phytate, health benefits, health effects, human nutrition

Abstract

hexakis -phosphate), a naturally compound formed during maturation of plant seeds and grains is a common constituent of plant-derived foods. This paper is aimed to review the scientific information concerning the potential health benefits and adverse effects associated with phytate in foods. The adverse health effects of phytate in the diet is its effect on mineral uptake. Minerals of concern in this regard would include Zn2+, Fe2+/3+, Ca2+, Mg2+, Mn2+, and Cu2+. Especially zinc and iron deficiencies were reported as a consequence of high phytate intakes. In addition, a the adverse effect on the nutritional value of protein by dietary phytate is discussed. Consumption of phytate, however, seems not to have only adverse health effects but also potential benefits on human health. Dietary phytate was reported to prevent kidney stone formation, protect against diabetes mellitus, caries, atherosclerosis and coronary heart disease as well as against a variety of cancers.

Downloads

How to Cite

Potential Health Benefits and Adverse Effects Associated with Phytate in Foods: A Review. (2014). Global Journal of Medical Research, 14(K3), 23-31. https://medicalresearchjournal.org/index.php/GJMR/article/view/709

Download Citation

References

Frank Loewus (2002) Biosynthesis of Phytate in Food Grains and Seeds. 53-61.

E Graf, J Eaton (1990) Antioxidant functions of phytic acid. 8, 61-69.

N Reddy, S Sathe, D Salunkhe (1982) Phytates in legumes and cereals. 28, 1-92.

D Cosgrove (1980) Inositol Phosphates Their Chemistry, Biochemistry and Physiology. 4, 122-129.

Munir Cheryan, Joseph Rackis (1980) Phytic acid interactions in food systems. 13(4), 297-335.

C Weaver, S Kannan (2002) Phytate and mineral bioavailability. 211-223.

R Greiner, U Konietzny, K-D Jany (2006) Phytate -an undesirable constituent of plant-based foods?. 8(3), 18-28.

F Grases, J March, R Prieto, B Simonet, A Costa-Bauzá, A García-Raja, A Conte (2000) Urinary phytate in calcium oxalate stones formers and healthy people. 34, 162-164.

Lilian Thompson (1993) Potential health benefits and problems associated with antinutrients in foods. 26(2), 131-149.

H Kaufman, I Kleinberg (1971) Effect of pH on calcium binding by phytic acid and its inositol phosphoric acid derivatives and on the solubility of their calcium salts. 16(4), 445-460.

Raxit Jariwalla, Robert Sabin, Stephen Lawson, Daniel Bloch, Marilyn Prender, Valerie Andrews, Zelek Herman (1990) Effects of dietary phytic acid (phytate) on the incidence and growth rate of tumors promoted in fischer rats by a magnesium supplement. 8(7), 813-827.

Bo Lönnerdal (2002) Phytic acid-trace element (Zn, Cu, Mn) interactions. 37(7), 749-758.

H Lopez, Fanny Leenhardt, Charles Coudray, Christian Remesy (2002) Minerals and phytic acid interactions: is it a real problem for human nutrition?. 37(7), 727-739.

D Oberleas (1983) The Role of Phytate in Zinc Bioavailability and Homeostasis. 145-158.

M Torre, A Rodriguez, F Saura-Calixto (1991) Effects of dietary fiber and phytic acid on mineral bioavailability. 1, 1-22.

A Askar, S El‐samahy, M Abd El‐fadeel (1983) Organic acids and free amino acids in some Egyptian fruits and vegetables. 26(1), 131-137.

A Wise (1983) Dietary factors determining the biological activities of phytate. 53, 791-806.

Mrs Fox, S-H Tao (1989) Antinutritive Effects of Phytate and Other Phosphorylated Derivatives. III, 59-96.

A Prasad, Miale Jr, A Farid, Z Sandstead, H Schulert, A (1963) Zinc metabolism in patients with the syndrome of iron deficiency anaemia, hepatosplenomegaly, dwarfism, and hypogonadism. 61, 537-549.

L Hallberg, L Rossander, A Skanberg (1987) Phytates and the inhibitory effect of bran on iron absorption in man. 45, 988-996.

M Brune, L Rossander-Hulthén, L Hallberg, A Gleerup, A Sandberg (1992) Iron absorption from bread in humans: Inhibiting effects of cereal fiber, phytate and inositol phosphates with different numbers of phosphate groups. 122, 442-449.

B Sandström, A Cederblad, B Kivistö, B Stenquist, H Andersson (1990) Retention of zinc and calcium from the human colon. 44(4), 501-504.

H Lantzsch, S Hillenbrand, S Scheuermann, K Menke (1992) Comparative study of phosphorus utilization from wheat, barley and corn diets by young rats and pigs. 67, 123-132.

Othmar Walz, Josef Pallauf (2002) Microbial phytase combined with amino acid supplementation reduces P and N excretion of growing and finishing pigs without loss of performance. 37(7), 835-848.

T Iqbal, K Lewis, B Cooper (1994) Phytase activity in the human and rat small intestine.. 35(9), 1233-1236.

(2008) CHEMICAL HAZARDS IN FOOD.

R Greiner, U Konietzny (2006) Phytase for Food Application. 44, 125-140.

M Oladimeji, A Akindahunsi, A Okafor (2000) Investigation of the bioavailability of zinc and calcium from some tropical tubers. 44(2), 136-137.

N Davis, S Warrington (1986) The phytic acid, mineral, trace element, protein and moisture content of UK Asian immigrant foods. 40, 49-59.

M Jenab, L Thompson (2002) Role of phytic acid in cancer and other diseases. 8, 64-74.

Abulkalam Shamsuddin (2002) Anti-cancer function of phytic acid. 37(7), 769-782.

C Barker, P Berggren (1999) Inositol hexakisphosphate and beta-cell stimulus secretion coupling. 19, 3737-3742.

Ramasamy Selvam (2002) Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. 30(1), 35-47.

Michael Golden (2009) Proposed Recommended Nutrient Densities for Moderately Malnourished Children. 30(3_suppl3).

M Bhandari, J Kawabata (2004) Cooking effects on oxalate, phytate, trypsin, cyanide and amylase inhibitors of wild yam tubers of Nepal. 19, 524-530.

A Sandberg (1991) The effect of food processing on phytate hydrolysis and availability of iron and zinc. 499-508.

C Simpson, A Wise (1990) Binding of zinc and calcium to inositol phosphates (phytate) in vitro. 64(1), 225-232.

Lena Davidsson, Pilar Galan, Peter Kastenmayer, Françoise Cherouvrier, Marcel Juillerat, Serge Hercberg, Richard Hurrell (1994) Iron Bioavailability Studied in Infants: The Influence of Phytic Acid and Ascorbic Acid in Infant Formulas Based on Soy Isolate. 36(6), 816-822.

M Gillooly, T Bothwell, J Torrance, A Macphail, D Derman, W Bezwoda, W Mills, R Charlton, F Mayet (1983) The effects of organic acids, phytates and polyphenols on the absorption of iron from vegetables. 49, 331-342.

D Siegenberg, R Baynes, T Bothwell, B Macfarlane, R Lamparelli, N Car, P Macphail, U Schmidt, A Tal, F Mayet (1991) Ascorbic acid prevents the dose-phytates on nonheme-iron absorption. 53, 537-541.

A Sandberg, L Rossander-Hulthén, M Türk (1996) Dietary Aspergillus niger phytase increases iron absorption in humans. 126, 476-480.

A Sandberg, T Larsen, B Sandström (1993) High dietary calcium level decreases colonic phytate degradation in pigs fed a rapeseed diet. 123, 559-566.

Alan Wise, David Gilburt (1987) Caecal Microbial Phytate Hydrolysis in the Rat. 41(1), 47-54.

M Brune, L Rossander, L Hallberg (1989) Iron absorption: no intestinal adaptation to a high-phytate diet. 49, 542-545.

S Deshpande, Munir Cheryan (1984) Effects of Phytic Acid, Divalent Cations, and Their Interactions on α‐Amylase Activity. 49(2), 516-519.

B Knuckles, A Betschart (1987) Effect of Phytate and Other Myo‐inositol Phosphate Esters on α‐Amylase Digestion of Starch. 52(3), 719-721.

B Knuckles (1988) Effect of Phytate and Other Myo‐Inositol Phosphate Esters on Lipase Activity. 53(1), 250-252.

S Deshpande, S Damodaran (1989) Effect of phytate on solubility, activity and conformation of trypsin and chymotrypsin. 54, 695-699.

Junichi Inagawa, Isao Kiyosawa, Taro Nagasawa (1987) Effects of phytic acid on the digestion of casein and soybean protein with trypsin, pancreatin or pepsin.. 40(5), 367-373.

Madhav Singh, A Krikorian (1982) Inhibition of trypsin activity in vitro by phytate. 30(4), 799-800.

J Yoon, L Thompson, Dja Jenkins (1983) The effect of phytic acid on in vitro rate of starch digestibility and blood glucose response. 38(6), 835-842.

Felix Grases, Bartolomé Simonet, Rafael Prieto, Juan March (2001) Variation of InsP4,InsP5 and InsP6 levels in tissues and biological fluids depending on dietary phytate. 12(10), 595-601.

A Wise (1981) Protective action of calcium phytate against acute lead toxicity in mice. 27, 630-633.

A Wise (1982) Blood lead levels after chronic feeding to mice of lead acetate with calcium phytate in the diet. 29, 550-553.

G Jackl, W Rambeck, W Koumer (1985) Retention of cadmium in organs of the rat after a single dose of labelled cadmium-3-phytate. 7, 69-74.

G Rimbach, J Pallauf, O Walz (1996) Effect of microbial phytase on cadmium accumulation in pigs. 49(4), 279-286.

Susan Potter (1995) Overview of Proposed Mechanisms for the Hypocholesterolemic Effect of Soy. 125, 606S-611S.

L Klevay (1975) Coronary heart disease: the Zinc/Copper hypothesis. 28, 764-774.

L Klevay (1973) Hypercholesterolemia in rats produced by an increase in the ratio of zinc to copper ingested. 26, 1060-1068.

H Persson, M Türk, M Nyman, A Sandberg (1998) Binding of Cu2+, Zn2+, and Cd2+ to inositol tri-, tetra-, penta-, and hexaphosphates. 46, 3194-3200.

Jin Zhou, John Erdman (1995) Phytic acid in health and disease. 35(6), 495-508.

Tadashi Ohkawa, Shoichi Ebisuno, Michio Kitagawa, Shigeyoshi Morimoto, Yoshihisa Miyazaki, Shu Yasukawa (1984) Rice Bran Treatment for Patients with Hypercalciuric Stones: Experimental and Clinical Studies. 132(6), 1140-1145.

F Grases, A Costa-Bauzá (1999) Phytate (IP6) is a powerful agent preventing calcifications in biological fluids: usefulness in renal lithiasis treatment. 19, 3717-3722.

F Grases, J Perello, R Prieto, B Simonet, J Torres (2004) Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats. 75, 11-19.

Ernst Graf, John Eaton (1985) Dietary suppression of colonic cancer fiber or phytate?. 56(4), 717-718.

Giorgio Deliliers, Federica Servida, Nicola Fracchiolla, Clara Ricci, Chiara Borsotti, Gualtiero Colombo, Davide Soligo (2002) Effect of inositol hexaphosphate (IP₆) on human normal and leukaemic haematopoietic cells. 117(3), 577-587.

A Shamsuddin, A Baten, N Lalwani (1992) Effects of inositol hexaphosphate on growth and differentiation in K-562 erythroleukemia cell line. 64, 195-202.

K Sakamoto, G Venkatraman, A Shamsuddin (1993) Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid). 14, 1815-1819.

A Shamsuddin, G Yang, I Vucenik (1996) Novel anticancer functions of IP6: Growth inhibition and differentiation of human mammary cancer cell lines in vitro. 16, 3287-3292.

S Ferry, M Matsuda, H Yoshida, M Hirata (2002) Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFkappaB-mediated cell survival pathway. 23(12), 2031-2041.

A Shamsuddin, G Yang (2003) Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDKcyclin and pRbrelated protein-E2F complexes. 24, 555-563.

X Zi, R Singh, R Agarwal (2000) Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells. 21(12), 2225-2235.

I Vucenik, K Tantivejkul, Z Zhang, K Cole, I Saied, A Shamsuddin (1998) IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 hunman liver cancer cell line. 18, 4083-4090.

I Vucenik, V Tomazic, D Fabian, A Shamsuddin (1992) Antitumor activity of phytic acid (inositol hexaphosphate) in murine transplanted and metastatic fibrosarcoma, a pilot study. 65, 9-13.

I Vucenik, T Kalebic, K Tantivejkul, A Shamsuddin (1998) Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo. 18, 1377-1384.

G Yang, A Shamsuddin (1995) IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: Involvement of intracellular inositol phosphates. 15, 2479-2488.

Masao Hirose, Toru Hoshiya, Keisuke Akagi, Mitsuru Futakuchi, Nobuyuki Ito (1994) Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[a]anthracene. 83(1-2), 149-156.

N Shivapurkar, Z Tang, A Frost, O Alabaster (1996) A rapid dual organ rat carcinogenesis bioassay for evaluating the chemoprevention of breast and colon cancer. 100, 169-179.

Ivana Vucenik, Kosaku Sakamoto, Mini Bansal, Abulkalam Shamsuddin (1993) Inhibition of rat mammary carcinogenesis by inositol hexaphosphate (phytic acid). A pilot study. 75(2), 95-102.

I Vucenik, G Yang, A Shamsuddin (1995) Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. 16, 1055-1058.

I Vucenik, G Yang, A Shamsuddin (1997) Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. 28, 7-13.

T Ishikawa, Y Nakatsuru, M Zarkovic, A Shamsuddin (1999) Inhibition of skin cancer by IP6 in vivo: Initiationpromotion model. 19, 3749-3752.

I Vucenik, Z Zhang, A Shamsuddin (1998) IP6 in treatment of liver cancer. II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice. 18, 4091-4096.

A Shamsuddin, A Ullah, A Chakravarthy (1989) Inositol and inositol hexaphosphate suppress cell proliferation and tumor formation in CD-1 mice. 10, 1461-1463.

S Shears (1998) The versatility of inositol phosphates as cellular signals. 1436, 49-67.

T Maffucci, E Piccolo, A Cumashi, M Iezzi, A Riley, A Saiardi, H Godage, C Rossi, M Broggini, S Iacobelli, Bvl Potter, P Innocenti, M Falasca (2005) Inhibition of the phosphatidylinositol 3-Kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. 65, 8339-8349.

Fiona Foster, Colin Traer, Siemon Abraham, Michael Fry (2003) The phosphoinositide (PI) 3-kinase family. 116(15), 3037-3040.

Tania Maffucci, Marco Falasca (2001) Specificity in pleckstrin homology (PH) domain membrane targeting: a role for a phosphoinositide-protein co‐operative mechanism. 506(3), 173-179.

P Carmeliet (2003) Angiogenesis in health and disease. 9, 653-660.

A Baten, A Ullah, V Tomazic, A Shamsuddin (1989) Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression. 10, 1595-1598.

P Hawkins, D Poyner, T Jackson, A Letcher, D Lander, R Irvine (1993) Inhibition of iron-catalysed hydroxyl radical formation by inositol polyphosphates: a possible physiological function for myo-inositol hexakisphosphate. 294(3), 929-934.

Brian Phillippy, Ernst Graf (1997) Antioxidant functions of Inositol 1,2,3-trisphosphate and Inositol 1,2,3,6-tetrakisphosphate. 22(6), 939-946.

Marc Basson, Gregory Turowski, Zaihan Rashid, Fu Hong, Joseph Madri (1996) Regulation of human colonic cell line proliferation and phenotype by sodium butyrate. 41(10), 1986-1993.

D Coradini, C Pellizzaro, D Marimpietri, G Abolafio, M Daidone (2000) Sodium butyrate modulates cell cyclerelated proteins in HT29 human colonic adenocarcinoma cells. 33, 139-146.

Harold Newmark, Joanne Lupton (1990) Determinants and consequences of colonic luminal pH: Implications for colon cancer. 14(3-4), 161-173.

A Mallett, C Bearne, I Rowland (1989) The influence of incubation pH on the activity of rat and human gut flora enzymes. 66(5), 433-437.

J Thornton (1981) High colonic pH promotes colorectal cancer. 1, 1081-1083.